Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.48 is 15% below its 5-year average of 4.09, near the low end of its 5-year range (2.75–5.59).
As of the fiscal period ended Tuesday, June 30, 2026. 4.70% below its 12-month average of 3.65.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.48.
CURRENT RATIO
3.48
CURRENT RATIO AVG TTM
3.65
CURRENT RATIO AVG 3Y
3.46
CURRENT RATIO AVG 5Y
4.09
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.70%
CURRENT VS 3Y AVG
+0.41%
CURRENT VS 5Y AVG
-14.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-7.23%
vs the sector median at left
Harmony Biosciences Holdings, Inc.
Market Cap
$2.28B
Current Ratio
3.48
TTM Avg
3.65
3Y Avg
3.46
5Y Avg
4.09
Market Cap
$2.24B
Current Ratio
11.85
TTM Avg
5.21
3Y Avg
5.21
5Y Avg
5.21
Market Cap
$2.38B
Current Ratio
1.50
TTM Avg
1.54
3Y Avg
1.54
5Y Avg
1.56
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | $2.28B | 3.48 | 3.65 | 3.46 | 4.09 |
| Liquidia Corporation (LQDA)vs › | $2.30B | 2.31 | 2.92 | 5.50 | 6.00 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | 11.85 | 5.21 | 5.21 | 5.21 |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | 3.00 | 2.62 | 2.45 | 2.80 |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | 6.34 | 6.74 | 5.35 | 5.46 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 6.97 | 6.34 | 6.18 | 6.55 |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | 24.14 | 21.55 | 17.24 | 12.65 |
| Pharvaris N.V. (PHVS)vs › | $2.17B | 11.94 | 11.36 | 14.78 | 18.07 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | 1.50 | 1.54 | 1.54 | 1.56 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | 4.05 | 7.06 | 7.46 | 6.71 |
Current Ratio
3.48
Quick Ratio
3.45
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.48 |
| 2026-03-31 | 3.58 |
| 2025-12-31 | 3.60 |
| 2025-09-30 | 3.75 |
| 2025-06-30 | 3.84 |
| 2025-03-31 | 3.67 |
| 2024-12-31 | 3.31 |
| 2024-09-30 | 3.24 |
| 2024-06-30 | 3.13 |
| 2024-03-31 | 3.11 |
| 2023-12-31 | 2.75 |
| 2023-09-30 | 4.12 |
| 2023-06-30 | 4.90 |
| 2023-03-31 | 4.90 |
| 2022-12-31 | 5.07 |
| 2022-09-30 | 3.56 |
| 2022-06-30 | 4.91 |
| 2022-03-31 | 4.96 |
| 2021-12-31 | 5.29 |
| 2021-09-30 | 5.05 |
| 2021-06-30 | 5.59 |
| 2021-03-31 | 5.32 |
| 2020-12-31 | 1.95 |
| 2020-09-30 | 7.87 |
| 2020-06-30 | 4.67 |
| 2020-03-31 | 5.50 |
| 2019-12-31 | 1.58 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
